Search results
Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and...
FOX21 Colorado Springs· 6 hours agoAge-related macular degeneration (AMD) is a leading cause of severe vision loss for people aged 50 years and older in developed countries worldwide, with ...
EyePoint Pharmaceuticals’ stock plunges as eye treatment fails to meet trial goal
Market Watch· 3 days agodropped nearly 30% in premarket trading Monday after the company said its experimental...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days ago(NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for < ...
Can At-Home Vision Tests Detect Active Neovascular AMD?
MedPage Today· 7 days agoThree at-home vision-monitoring tools failed to detect worsening neovascular age-related macular ...
Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
Benzinga via Yahoo Finance· 3 days agoOn Monday, EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT) announced the topline results of its Phase 2...
EyePoint tumbles 30% premarket on failed Phase 2 study (NASDAQ:EYPT)
Seeking Alpha· 3 days agoEyePoint (EYPT) stock tumbled nearly 30% in premarket trading Monday after the company said a Phase...
Ocular Therapeutix stock target cut, Buy rating kept By Investing.com
Investing.com· 14 hours agoOn Wednesday, H.C. Wainwright adjusted its price target on shares of Ocular Therapeutix...
ASGCT: Ring's 'new class of viral vector' is re-dosable in primates, overcoming key challenge of...
FierceBiotech· 6 hours agoPandemic aside, things were going well for Tuyen Ong, M.D. The physician and biotech entrepreneur...
EyePoint reports mixed results in diabetic retinopathy trial By Investing.com
Investing.com· 2 days agoEyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:EYPT) announced interim results from its Phase 2...
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Zacks via Yahoo Finance· 7 days agoIn August 2023, the FDA approved Eylea HD (higher dose of Eylea) for the treatment of patients with ...